TSLA Tesla, Inc.
Nasdaq · Consumer Cyclical · AI Robotics & autonomy
Tue, Nov 10
0.6× volume
+0.5%
Mon, Nov 9
0.9× volume
+5.5%
Fri, Nov 6
0.9× volume
+4.2%
Thu, Nov 5
2.1× volume
-10.8%
Wed, Nov 4
1.3× volume
-3.3%
Tue, Nov 3
0.7× volume
-1.3%
Mon, Nov 2
1.2× volume
+1.0%
Top holding of TSHI.TO 125.9%, TSLY.TO 122.9%, VCR 16.1%, XLY 15.9%, CARD 12.8%, CARU 11.8%, ARKK 10.3%, DISC.TO 9.9%
News this week
- Finland approves Tesla’s Assisted Driving system
- US SEC seeks to close Musk, Tesla settlement fund
- YieldMax TSLA Performance & Distribution Target 25 ETF declares $0.1739 dividend
- Tesla Cybertruck is EV pickup market’s latest casualty
- Biggest stock movers Monday: NVDA, VIR, and more
- Why is Tesla stock rallying today?
- Tesla to refund many Cybertruck deposits as demand exceeds production, Musk says
- The long, strange trip of Tesla's Cybertruck
- Tesla to expand Cybertruck production in bid to fill orders before dismantling line next year
- Stephen Miller Is Trump’s New Chief of Staff
- AMD, Tesla among market cap stock movers on Thursday
- Tesla to end cybertruck production at Texas factory by mid-2027 to ramp up Cybercab output, Musk says
- Why is Tesla stock rallying today?
- Tesla support and resistance levels to watch now
- The ‘Musk selloff’ deepens as Tesla and SpaceX combine for $450 billion two-day wipeout
- Forum Mobility Announces Ribbon-Cutting Event for First Ultra-Fast MCS Chargers in SoCal Port Gateway at FM Harbor
- Why is Tesla stock sliding today?
- Stocks making the biggest moves after hours: Coherent, AppLovin, Expedia, Qualcomm and more
- Tesla moved to Austin - now its biggest headwind might be Austin politicians
- BofA adds TSLA, AVGO, IBM, others to its Global Defenders list
- Musk's Tesla and SpaceX slip as early US midterm results point to democratic wins
- Elon Musk’s business empire braces for Democratic wave as Texas flips blue
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- Stocks making the biggest moves premarket: Trump Media, Tesla, CoreWeave, Novo Nordisk and more